Exxel Pharma, INC.

CIK 2046638 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Exxel Pharma, INC..

Recent SEC filings

FiledFormAccession number
Feb 20, 2026FWP0001213900-26-018793
Feb 13, 2026FWP0001213900-26-015696
Feb 2, 2026S-1/A0001213900-26-010410
Oct 14, 2025S-1/A0001213900-25-098577
Sep 19, 2025S-10001213900-25-089404
Dec 2, 2024D0002046638-24-000001